newsfilter
← Latest News
GlobeNewswire·

Aequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products

VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company") is pleased to announce the signing of an exclusive distribution agreement with SCOPE Ophthalmics. ("SCOPE"),